SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

N/A

Manufactured by DNA Labs

1,037 FDA adverse event reports analyzed

Last updated: 2026-04-15

About SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by DNA Labs. The most commonly reported adverse reactions for SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE include DIARRHOEA, PAIN, HEADACHE, FATIGUE, NAUSEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE.

Top Adverse Reactions

DIARRHOEA33 reports
PAIN33 reports
HEADACHE30 reports
FATIGUE29 reports
NAUSEA27 reports
ARTHRALGIA26 reports
DIZZINESS24 reports
PAIN IN EXTREMITY21 reports
ASTHENIA18 reports
ABDOMINAL PAIN UPPER17 reports
EYE PAIN17 reports
GAIT DISTURBANCE17 reports
MALAISE17 reports
MUSCLE SPASMS17 reports
DYSPNOEA16 reports
FALL16 reports
FEELING ABNORMAL16 reports
CONSTIPATION15 reports
DEPRESSION15 reports
DRUG INEFFECTIVE15 reports
INSOMNIA15 reports
PRURITUS15 reports
ALOPECIA14 reports
PARAESTHESIA14 reports
PRODUCT DOSE OMISSION ISSUE14 reports
BLOOD PRESSURE INCREASED13 reports
HYPOAESTHESIA13 reports
PNEUMONIA13 reports
RASH13 reports
VOMITING13 reports
WEIGHT DECREASED13 reports
WEIGHT INCREASED13 reports
DEATH12 reports
CONFUSIONAL STATE11 reports
FLUSHING11 reports
VISION BLURRED11 reports
BACK PAIN10 reports
MIGRAINE10 reports
MULTIPLE SCLEROSIS RELAPSE10 reports
OFF LABEL USE10 reports
PRODUCT SUBSTITUTION ISSUE10 reports
TREMOR10 reports
ANXIETY9 reports
BALANCE DISORDER9 reports
DECREASED APPETITE9 reports
PERIPHERAL SWELLING9 reports
CONDITION AGGRAVATED8 reports
NEUROPATHY PERIPHERAL8 reports
PALPITATIONS8 reports
PRODUCT DOSE OMISSION8 reports
URTICARIA8 reports
ABDOMINAL DISCOMFORT7 reports
CHEST PAIN7 reports
CHILLS7 reports
CONTUSION7 reports
COVID 197 reports
DRUG DOSE OMISSION7 reports
DYSPEPSIA7 reports
HOT FLUSH7 reports
INTENTIONAL PRODUCT MISUSE7 reports
MEMORY IMPAIRMENT7 reports
VISUAL IMPAIRMENT7 reports
BLOOD GLUCOSE INCREASED6 reports
BURNING SENSATION6 reports
CHRONIC KIDNEY DISEASE6 reports
DRUG INTOLERANCE6 reports
GASTROINTESTINAL DISORDER6 reports
ILLNESS6 reports
JOINT SWELLING6 reports
MYALGIA6 reports
NASOPHARYNGITIS6 reports
OROPHARYNGEAL PAIN6 reports
PYREXIA6 reports
SEIZURE6 reports
SOMNOLENCE6 reports
THERAPY CESSATION6 reports
ARTHRITIS5 reports
CATARACT5 reports
COUGH5 reports
DEHYDRATION5 reports
DRUG HYPERSENSITIVITY5 reports
EPISTAXIS5 reports
FEELING HOT5 reports
GASTROOESOPHAGEAL REFLUX DISEASE5 reports
HAEMORRHAGE5 reports
HYPERSENSITIVITY5 reports
INFLUENZA LIKE ILLNESS5 reports
MUSCULOSKELETAL STIFFNESS5 reports
MYOCARDIAL INFARCTION5 reports
PRODUCT USE ISSUE5 reports
SKIN EXFOLIATION5 reports
SUICIDAL IDEATION5 reports
VERTIGO5 reports
ABDOMINAL PAIN4 reports
ACUTE KIDNEY INJURY4 reports
AMNESIA4 reports
ANGER4 reports
BLINDNESS4 reports
CEREBROVASCULAR ACCIDENT4 reports
CHEST DISCOMFORT4 reports

Report Outcomes

Out of 481 classified reports for SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE:

Serious 55.7%Non-Serious 44.3%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female331 (70.4%)
Male139 (29.6%)

Reports by Age

Age 7017 reports
Age 6515 reports
Age 6615 reports
Age 6814 reports
Age 7514 reports
Age 5813 reports
Age 7213 reports
Age 6411 reports
Age 7111 reports
Age 7411 reports
Age 7611 reports
Age 6110 reports
Age 6910 reports
Age 8110 reports
Age 739 reports
Age 829 reports
Age 528 reports
Age 678 reports
Age 477 reports
Age 547 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE?

This profile reflects 1,037 FDA FAERS reports that mention SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE?

Frequently reported terms in FAERS include DIARRHOEA, PAIN, HEADACHE, FATIGUE, NAUSEA, ARTHRALGIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE?

Labeling and FAERS entries often list DNA Labs in connection with SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.